1042 related articles for article (PubMed ID: 29166886)
21. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
22. Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study.
Penno G; Solini A; Bonora E; Fondelli C; Orsi E; Zerbini G; Trevisan R; Vedovato M; Gruden G; Laviola L; Nicolucci A; Pugliese G;
J Intern Med; 2013 Aug; 274(2):176-91. PubMed ID: 23565931
[TBL] [Abstract][Full Text] [Related]
23. Secular Trends in Lipid Profiles in Korean Adults Based on the 2005-2015 KNHANES.
Kwon YJ; Lee JW; Kang HT
Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31319575
[TBL] [Abstract][Full Text] [Related]
24. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
25. Gender and Race Disparities in Cardiovascular Disease Risk Factors among New York City Adults: New York City Health and Nutrition Examination Survey (NYC HANES) 2013-2014.
Kanchi R; Perlman SE; Chernov C; Wu W; Tabaei BP; Trinh-Shevrin C; Islam N; Seixas A; Rodriguez-Lopez J; Thorpe LE
J Urban Health; 2018 Dec; 95(6):801-812. PubMed ID: 29987772
[TBL] [Abstract][Full Text] [Related]
26. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
[TBL] [Abstract][Full Text] [Related]
27. Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic.
Chmelík Z; Vaclová M; Lánská V; Laštůvka J; Vrablík M
Cent Eur J Public Health; 2020 Jun; 28(2):114-119. PubMed ID: 32592555
[TBL] [Abstract][Full Text] [Related]
28. Twenty-year trends in cardiovascular risk factors in India and influence of educational status.
Gupta R; Guptha S; Gupta VP; Agrawal A; Gaur K; Deedwania PC
Eur J Prev Cardiol; 2012 Dec; 19(6):1258-71. PubMed ID: 21947630
[TBL] [Abstract][Full Text] [Related]
29. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM; Candrilli SD; Kanyongo G
Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
[TBL] [Abstract][Full Text] [Related]
30. Magnitude of and gender differences in cardiovascular risk profiles among community residents in Shenzhen, China.
Li H; Yan X; Deng X; Yang L; Zhao S; Zou J; Luo Y; Cao S
Public Health; 2017 Jun; 147():59-65. PubMed ID: 28404497
[TBL] [Abstract][Full Text] [Related]
31. Trends in major risk factors and mortality from main non-communicable diseases in Lithuania, 1985-2013.
Tamosiunas A; Klumbiene J; Petkeviciene J; Radisauskas R; Vikhireva O; Luksiene D; Virviciute D
BMC Public Health; 2016 Aug; 16():717. PubMed ID: 27492379
[TBL] [Abstract][Full Text] [Related]
32. Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia.
Bays HE; Chapman RH; Fox KM; Grandy S;
Curr Med Res Opin; 2008 Apr; 24(4):1179-86. PubMed ID: 18346311
[TBL] [Abstract][Full Text] [Related]
33. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
Du T; Yuan G; Zhou X; Sun X
Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
Chopra I; Kamal KM
Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
[TBL] [Abstract][Full Text] [Related]
35. Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study.
Koopal C; Retterstøl K; Sjouke B; Hovingh GK; Ros E; de Graaf J; Dullaart RP; Bertolini S; Visseren FL
Atherosclerosis; 2015 May; 240(1):90-7. PubMed ID: 25768710
[TBL] [Abstract][Full Text] [Related]
36. Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy.
Figliuzzi I; Presta V; Citoni B; Miceli F; Simonelli F; Battistoni A; Coluccia R; Ferrucci A; Volpe M; Tocci G
Clin Cardiol; 2018 Jun; 41(6):788-796. PubMed ID: 29604091
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
[TBL] [Abstract][Full Text] [Related]
38. Measures of adiposity and cardiovascular disease risk factors, New York City Health and Nutrition Examination Survey, 2004.
Gwynn RC; Berger M; Garg RK; Waddell EN; Philburn R; Thorpe LE
Prev Chronic Dis; 2011 May; 8(3):A56. PubMed ID: 21477496
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations.
Gaziano TA; Abrahams-Gessel S; Alam S; Alam D; Ali M; Bloomfield G; Carrillo-Larco RM; Dorairaj P; Gutierrez L; Irazola V; Levitt NS; Miranda JJ; Bernabe-Ortiz A; Pandya A; Rubinstein A; Steyn K; Xavier D; Yan LL
Glob Heart; 2016 Mar; 11(1):37-46.e2. PubMed ID: 27102021
[TBL] [Abstract][Full Text] [Related]
40. Risk Factor Control in Stroke Survivors with Diagnosed and Undiagnosed Diabetes: A Ghanaian Registry Analysis.
Sarfo FS; Akassi J; Agyei M; Kontoh S; Ovbiagele B
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105304. PubMed ID: 32992189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
